Lung adenocarcinoma, dermatomyositis, and Lambert-Eaton myasthenic syndrome: A rare combination;Adenocarcinoma pulmonar, dermatomiosite e síndrome miastênica de Lambert-Eaton: Uma rara associação*

Jornal Brasileiro de Pneumologia

Volumn 34, Issue 5, 2008, Pages 333-336

  Milanez, Fernanda Manente ^a   Pereira, Carlos Alberto De Castro ^a   Trindade, Pedro Henrique Duccini Mendes ^a   Milinavicius, Ricardo ^a   Coletta, Ester Nei Aparecida Martins ^a  

^a HOSPITAL DO SERVIDOR PÚBLICO ESTADUAL DE SÃO PAULO   (Brazil)

Author keywords

Adenocarcinoma; Dermatomyositis; Lambert Eaton myasthenic syndrome; Lung neoplasms; Paraneoplastic syndromes

Indexed keywords

EID: 45349092837     PISSN: 18063713     EISSN: 18063713     Source Type: Journal    
DOI: 10.1590/s1806-37132008000500014     Document Type: Article

References (19)

1. GLOBOCAN 2000. Cancer Incidence, Mortality and Prevalence Worldwide. Version 1.0. Lyon: IARCPress; 2001.
2. Miller DW, Hahn JF. General methods of clinical examination. In: Youmans JR, editor. Neurological Surgery: A Comprehensive Reference Guide to the Diagnosis and Management of Neurosurgical Problems. 4th ed. Philadelphia: W. B. Saunders; 1996. p. 31-32.
3. Estimativas para o ano de 2006 de números de casos novos por câncer, em homens e mulheres, segundo localização primária (Brasil). In: Estimativa 2006: Incidência de câncer no Brasil. Rio de Janeiro: INCA; 2005. p. 39-40.
4. Collins LG, Haines C, Perkel R, Enck RE. Lung cancer: diagnosis and management. Am Fam Physician. 2007;75(1):56-63.
5. Hoffman PC, Mauer AM, Vokes EE. Lung cancer.Lancet. 2000;355(9202):479- 85.
6. Koler RA, Montemarano A. Dermatomyositis. Am Fam Physician. 2001;64(9):1565-72.
7. Lin JT, Lachmann E. Lambert-eaton myasthenic syndrome: a case report and review of the literature. J Womens Health (Larchmt). 2002;11(10):849-55.
8. Dourmishev LA, Dourmishev AL, Schwartz RA. Dermatomyositis: cutaneous manifestations of its variants. Int J Dermatol. 2002;41(10):625-30.
9. Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292(7):344-7.
10. Callen JP. Dermatomyositis. Lancet. 2000;355(9197):53-7.
11. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003;362(9388):971-82.
12. del Pozo J, Almagro M, Martínez W, Yebra-Pimentel MT, García-Silva J, Peña-Penabad C, et al. Dermatomyositis and mucinosis. Int J Dermatol. 2001;40(2):120-4.
13. Fam AG. Paraneoplastic rheumatic syndromes. Baillieres Best Pract Res Clin Rheumatol. 2000;14(3):515-33.
14. Stone SP, Buescher LS. Life-threatening paraneoplastic cutaneous syndromes. Clin Dermatol. 2005;23(3):301-6.
15. Yang Y, Fujita J, Tokuda M, Bandoh S, Ishida T. Lung cancer associated with several connective tissue diseases: with a review of literature. Rheumatol Int. 2001;21(3):106-11.
16. Fujita J, Tokuda M, Bandoh S, Yang Y, Fukunaga Y, Hojo S, et al. Primary lung cancer associated with polymyositis/dermatomyositis, with a review of the literature. Rheumatol Int. 2001;20(2):81-4.
17. Hill CL, Zhang Y, Sigurgeirsson B, Pukkala E, Mellemkjaer L, Airio A, et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet. 2001;357(9250):96-100.
18. Stojic AS, Mekhail T, Tsao BE. Leg weakness in a 66-year-old woman: a common presentation of an uncommon disease. Cleve Clin J Med. 2007;74(1):23-6, 29-34.
19. de Beukelaar JW, Sillevis Smitt PA. Managing paraneoplastic neurological disorders. Oncologist. 2006;11(3):292-305.